The influence of ovariectomy, simvastatin and sodium alendronate on alveolar bone in rats

Detalhes bibliográficos
Autor(a) principal: Anbinder,Ana Lia
Data de Publicação: 2007
Outros Autores: Prado,Fernanda de Almeida, Prado,Marcela de Almeida, Balducci,Ivan, Rocha,Rosilene Fernandes da
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Brazilian Oral Research
Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1806-83242007000300010
Resumo: Bisphosphonates are currently used in the treatment of many diseases involving increased bone resorption such as osteoporosis. Statins have been widely used for the treatment of hypercholesterolemia and recent studies have shown that these drugs are also capable of stimulating bone formation. The purpose of this study was to evaluate the influence of an estrogen deficient state and the effects of simvastatin and sodium alendronate therapies on alveolar bone in female rats. Fifty-four rats were either ovariectomized (OVX) or sham operated. A month later, the animals began to receive a daily dose of simvastatin (SIN - 25 mg/kg), sodium alendronate (ALN - 2 mg/kg) or water (control) orally. Thirty-five days after the beginning of the treatment, the rats were sacrificed and their left hemimandibles were removed and radiographed using digital X-ray equipment. The alveolar radiographic density under the first molar was determined with gray-level scaling and the values were submitted to analysis of variance (a = 5%). Ovariectomized rats gained more weight (mean ± standard deviation: 20.06 ± 6.68%) than did the sham operated animals (12.13 ± 5.63%). Alveolar radiographic density values, expressed as gray levels, were lowest in the OVX-water group (183.49 ± 6.47), and differed significantly from those observed for the groups receiving alendronate (sham-ALN: 193.85 ± 3.81; OVX-ALN: 196.06 ± 5.11) and from those of the sham-water group (193.66 ± 4.36). Other comparisons between groups did not show significant differences. It was concluded that the ovariectomy reduced alveolar bone density and that alendronate was efficient for the treatment of this condition.
id SBPQO-1_304ed43f14df0cfb9ed1dc7e7099e0db
oai_identifier_str oai:scielo:S1806-83242007000300010
network_acronym_str SBPQO-1
network_name_str Brazilian Oral Research
repository_id_str
spelling The influence of ovariectomy, simvastatin and sodium alendronate on alveolar bone in ratsAlendronateModels, animalOsteoporosisOvariectomySimvastatinBisphosphonates are currently used in the treatment of many diseases involving increased bone resorption such as osteoporosis. Statins have been widely used for the treatment of hypercholesterolemia and recent studies have shown that these drugs are also capable of stimulating bone formation. The purpose of this study was to evaluate the influence of an estrogen deficient state and the effects of simvastatin and sodium alendronate therapies on alveolar bone in female rats. Fifty-four rats were either ovariectomized (OVX) or sham operated. A month later, the animals began to receive a daily dose of simvastatin (SIN - 25 mg/kg), sodium alendronate (ALN - 2 mg/kg) or water (control) orally. Thirty-five days after the beginning of the treatment, the rats were sacrificed and their left hemimandibles were removed and radiographed using digital X-ray equipment. The alveolar radiographic density under the first molar was determined with gray-level scaling and the values were submitted to analysis of variance (a = 5%). Ovariectomized rats gained more weight (mean ± standard deviation: 20.06 ± 6.68%) than did the sham operated animals (12.13 ± 5.63%). Alveolar radiographic density values, expressed as gray levels, were lowest in the OVX-water group (183.49 ± 6.47), and differed significantly from those observed for the groups receiving alendronate (sham-ALN: 193.85 ± 3.81; OVX-ALN: 196.06 ± 5.11) and from those of the sham-water group (193.66 ± 4.36). Other comparisons between groups did not show significant differences. It was concluded that the ovariectomy reduced alveolar bone density and that alendronate was efficient for the treatment of this condition.Sociedade Brasileira de Pesquisa Odontológica - SBPqO2007-09-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S1806-83242007000300010Brazilian Oral Research v.21 n.3 2007reponame:Brazilian Oral Researchinstname:Sociedade Brasileira de Pesquisa Odontológica (SBPqO)instacron:SBPQO10.1590/S1806-83242007000300010info:eu-repo/semantics/openAccessAnbinder,Ana LiaPrado,Fernanda de AlmeidaPrado,Marcela de AlmeidaBalducci,IvanRocha,Rosilene Fernandes daeng2009-10-19T00:00:00Zoai:scielo:S1806-83242007000300010Revistahttps://www.scielo.br/j/bor/https://old.scielo.br/oai/scielo-oai.phppob@edu.usp.br||bor@sbpqo.org.br1807-31071806-8324opendoar:2009-10-19T00:00Brazilian Oral Research - Sociedade Brasileira de Pesquisa Odontológica (SBPqO)false
dc.title.none.fl_str_mv The influence of ovariectomy, simvastatin and sodium alendronate on alveolar bone in rats
title The influence of ovariectomy, simvastatin and sodium alendronate on alveolar bone in rats
spellingShingle The influence of ovariectomy, simvastatin and sodium alendronate on alveolar bone in rats
Anbinder,Ana Lia
Alendronate
Models, animal
Osteoporosis
Ovariectomy
Simvastatin
title_short The influence of ovariectomy, simvastatin and sodium alendronate on alveolar bone in rats
title_full The influence of ovariectomy, simvastatin and sodium alendronate on alveolar bone in rats
title_fullStr The influence of ovariectomy, simvastatin and sodium alendronate on alveolar bone in rats
title_full_unstemmed The influence of ovariectomy, simvastatin and sodium alendronate on alveolar bone in rats
title_sort The influence of ovariectomy, simvastatin and sodium alendronate on alveolar bone in rats
author Anbinder,Ana Lia
author_facet Anbinder,Ana Lia
Prado,Fernanda de Almeida
Prado,Marcela de Almeida
Balducci,Ivan
Rocha,Rosilene Fernandes da
author_role author
author2 Prado,Fernanda de Almeida
Prado,Marcela de Almeida
Balducci,Ivan
Rocha,Rosilene Fernandes da
author2_role author
author
author
author
dc.contributor.author.fl_str_mv Anbinder,Ana Lia
Prado,Fernanda de Almeida
Prado,Marcela de Almeida
Balducci,Ivan
Rocha,Rosilene Fernandes da
dc.subject.por.fl_str_mv Alendronate
Models, animal
Osteoporosis
Ovariectomy
Simvastatin
topic Alendronate
Models, animal
Osteoporosis
Ovariectomy
Simvastatin
description Bisphosphonates are currently used in the treatment of many diseases involving increased bone resorption such as osteoporosis. Statins have been widely used for the treatment of hypercholesterolemia and recent studies have shown that these drugs are also capable of stimulating bone formation. The purpose of this study was to evaluate the influence of an estrogen deficient state and the effects of simvastatin and sodium alendronate therapies on alveolar bone in female rats. Fifty-four rats were either ovariectomized (OVX) or sham operated. A month later, the animals began to receive a daily dose of simvastatin (SIN - 25 mg/kg), sodium alendronate (ALN - 2 mg/kg) or water (control) orally. Thirty-five days after the beginning of the treatment, the rats were sacrificed and their left hemimandibles were removed and radiographed using digital X-ray equipment. The alveolar radiographic density under the first molar was determined with gray-level scaling and the values were submitted to analysis of variance (a = 5%). Ovariectomized rats gained more weight (mean ± standard deviation: 20.06 ± 6.68%) than did the sham operated animals (12.13 ± 5.63%). Alveolar radiographic density values, expressed as gray levels, were lowest in the OVX-water group (183.49 ± 6.47), and differed significantly from those observed for the groups receiving alendronate (sham-ALN: 193.85 ± 3.81; OVX-ALN: 196.06 ± 5.11) and from those of the sham-water group (193.66 ± 4.36). Other comparisons between groups did not show significant differences. It was concluded that the ovariectomy reduced alveolar bone density and that alendronate was efficient for the treatment of this condition.
publishDate 2007
dc.date.none.fl_str_mv 2007-09-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1806-83242007000300010
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1806-83242007000300010
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.1590/S1806-83242007000300010
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Sociedade Brasileira de Pesquisa Odontológica - SBPqO
publisher.none.fl_str_mv Sociedade Brasileira de Pesquisa Odontológica - SBPqO
dc.source.none.fl_str_mv Brazilian Oral Research v.21 n.3 2007
reponame:Brazilian Oral Research
instname:Sociedade Brasileira de Pesquisa Odontológica (SBPqO)
instacron:SBPQO
instname_str Sociedade Brasileira de Pesquisa Odontológica (SBPqO)
instacron_str SBPQO
institution SBPQO
reponame_str Brazilian Oral Research
collection Brazilian Oral Research
repository.name.fl_str_mv Brazilian Oral Research - Sociedade Brasileira de Pesquisa Odontológica (SBPqO)
repository.mail.fl_str_mv pob@edu.usp.br||bor@sbpqo.org.br
_version_ 1750318321141547008